EMA First Regulator Globally to Approve Moderna's Dual mRNA Vaccine (arstechnica.com)

• First-in-world regulatory approval for combination mRNA vaccine
• Precedence over US regulatory timeline
• Strategic focus on healthcare system resilience and public immunity

"The European Medicines Agency (EMA) has granted the first global regulatory approval for Moderna’s combination mRNA vaccine, covering both seasonal influenza and COVID-19. This milestone positions Europe ahead of the U.S. in biotechnology deployment. By streamlining vaccine administration, the EU aims to bolster public health resilience against seasonal respiratory pathogen spikes, demonstrating strategic autonomy in healthcare policy and vaccine infrastructure."